Company intelligence / Profile preview

Aurex International Corporation

Ownership: Private
Development stage: Other

Overview

Aurex International has commercialized the Aurex-3, a wearable, bone conduction-based device for tinnitus management, leveraging patented use of beat harmonics and cloud connectivity for progress monitoring. Clinical results are not extensively detailed publicly, but the device is marketed for patient use[4].

Therapeutic areas: Neurology
Modalities: Device
Industry: Assistive Medical Devices

Partnerships

International network of audiologists for device monitoring[4]

Beyond the preview

Go deeper on Aurex International Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aurex International Corporation.

Explore the full profile